These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 535169

  • 1. Salivary 17 alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Walker RF, Hughes IA, Riad-Fahmy D.
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):631-7. PubMed ID: 535169
    [No Abstract] [Full Text] [Related]

  • 2. Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva.
    Hughes IA, Dyas J, Robinson J, Walker RF, Fahmy DR.
    Ann N Y Acad Sci; 1985 Dec; 458():193-202. PubMed ID: 3879122
    [No Abstract] [Full Text] [Related]

  • 3. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 4. Radioimmunoassay of 17alpha-hydroxyprogesterone in whole saliva and parotid fluid of children with congenital adrenal hyperplasia [proceedings].
    Walker RF, Fahmy DR.
    J Endocrinol; 1978 Nov 09; 79(2):64P-65P. PubMed ID: 731178
    [No Abstract] [Full Text] [Related]

  • 5. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
    Hampl R, Foretová L, Sulcová J, Stárka L.
    Eur J Pediatr; 1990 Jan 09; 149(4):232-4. PubMed ID: 2303071
    [Abstract] [Full Text] [Related]

  • 6. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
    Guechot J, Fiet J, Gourmelen M, Pham-Huu-Trung MT, Raux-Eurin MC, Brerault JL, Gueux B, Villette JM.
    Ann Biol Clin (Paris); 1985 Jan 09; 43(4):333-7. PubMed ID: 4091295
    [Abstract] [Full Text] [Related]

  • 7. Radioimmunoassay of 17 alpha-hydroxyprogesterone in saliva, parotid fluid, and plasma of congenital adrenal hyperplasia patients.
    Walker RF, Read GF, Hughes IA, Riad-Fahmy D.
    Clin Chem; 1979 Apr 09; 25(4):542-5. PubMed ID: 466763
    [Abstract] [Full Text] [Related]

  • 8. [Clinical assessment of the role of circadian rhythm of hormone contents in the blood and saliva of children with congenital dysfunction of the adrenal cortex].
    Fofanova OV.
    Pediatriia; 1989 Apr 09; (11):38-41. PubMed ID: 2608371
    [Abstract] [Full Text] [Related]

  • 9. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
    Hughes IA, Read GF.
    Horm Res; 1984 Apr 09; 19(2):77-85. PubMed ID: 6538545
    [Abstract] [Full Text] [Related]

  • 10. [Methodical approaches to the determination of steroid hormone levels in different biological fluids in children with congenital dysfunction of the adrenal cortex].
    Fofanova OV, Pankova SS, Kolesnikova GS.
    Pediatriia; 1989 Apr 09; (11):72-5. PubMed ID: 2608377
    [Abstract] [Full Text] [Related]

  • 11. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.
    Hubl W, Fehér T, Rohde W, Dörner G, Taubert H, Freymann E.
    Endokrinologie; 1982 Jun 09; 79(2):165-72. PubMed ID: 6751805
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous plasma and saliva steroid measurements as an index of control in congenital adrenal hyperplasia (CAH). A longitudinal study.
    Hughes IA, Read GF.
    Horm Res; 1982 Jun 09; 16(3):142-50. PubMed ID: 7106699
    [Abstract] [Full Text] [Related]

  • 13. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
    Vavrinec J, Dvorák P, Zizkovský V, Kopecký A, Pospísilová D, Starý J.
    Cesk Pediatr; 1983 Sep 09; 38(9):533-6. PubMed ID: 6315246
    [No Abstract] [Full Text] [Related]

  • 14. Serum 17-hydroxypregnenolone and 17-hydroxypregnenolone sulfate concentrations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Shimozawa K, Saisho S, Yata J, Kambegawa A.
    Endocrinol Jpn; 1988 Feb 09; 35(1):11-8. PubMed ID: 3260857
    [Abstract] [Full Text] [Related]

  • 15. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
    Parth K, Zimprich H, Swoboda W, Brunel R, Bohrn E.
    Acta Endocrinol (Copenh); 1978 Jan 09; 87(1):148-57. PubMed ID: 202131
    [No Abstract] [Full Text] [Related]

  • 16. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
    Winter JS, Couch RM.
    Ann N Y Acad Sci; 1985 Jan 09; 458():165-73. PubMed ID: 3879120
    [No Abstract] [Full Text] [Related]

  • 17. [17-hydroxyprogesterone in the diagnosis and treatment of adrenogenital syndrome].
    Cassorla F.
    Rev Chil Pediatr; 1982 Jan 09; 53(4):295-304. PubMed ID: 7163538
    [No Abstract] [Full Text] [Related]

  • 18. Identification of 17-hydroxyprogesterone and other steroid hormones in saliva from a normal child and patients with congenital adrenal hyperplasia by plasmaspray liquid chromatography/mass spectrometry.
    Shindo N, Yamauchi N, Murayama K, Fairbrother A, Korlik S.
    Biomed Chromatogr; 1990 Jul 09; 4(4):171-4. PubMed ID: 2207381
    [Abstract] [Full Text] [Related]

  • 19. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
    Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
    Rev Chil Pediatr; 1984 Jul 09; 55(6):374-9. PubMed ID: 6536989
    [No Abstract] [Full Text] [Related]

  • 20. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar 09; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.